GL1X · GenesisL1 explorer

Research workbench

AlphaFold monomer V2.0 prediction for serine hydroxymethyltransferase (Q2NEA8)

Analyse AlphaFold monomer V2.0 prediction for serine hydroxymethyltransferase (Q2NEA8) in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

Accession
Q2NEA8
Type
protein
Length
422 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0x79a905d858Ce72991FD6E7a9C6498620f42E146D
Molecule
Serine hydroxymethyltransferase
UniProt
Q2NEA8
Pockets
2 · best druggability 0.58

Structure

1 distinct chain · 46% helix, 13% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ASerine hydroxymethyltransferaseprotein42246% helix, 13% strandQ2NEA8

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13170.580.7626empty
2930.360.7518empty

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.